Mazumdar-Shaw appears on the list alongside global leaders from the industry, including CEOs, professors, Nobel Prize-winning researchers and many other celebrated scientists from the pharmaceutical world.
The Top 5 on 'The Medicine Maker Power List' include: Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, USA; Kiran Mazumdar-Shaw, Chairperson & MD, Biocon; Andrew Witty, CEO, GlaxoSmithKline; Arthur D Levinson, CEO, Calico and Heather Bresch, CEO, Mylan.
The list also includes names like Pascal Soriot, CEO, AstraZeneca; Robert A Bradway, Chairman & CEO, Amgen; Ian C Read, Chairman, Pfizer; Prof. Tyler Jacks, Koch Institute for Integrative Cancer Research; Charles Cooney, Massachusetts Institute of Technology, USA; Harold Varmus, Weil Cornell Medical College and many more.
Mazumdar-Shaw is the only India-based business leader featuring on the list. The drug maker is a UK-based publication that is distributed worldwide to a targeted European and North American industry professionals. The power list has been compiled from reader nominations with the help of expert judges and is based entirely on merit.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)